Find your path to Abby
94 people in our graph share verified history with Abby — schools, employers, funds. One of them is your warm intro.
Christopher WolfunlockedAbby: together at Northeastern University (1993–1994)
×10Abby: together at Northeastern University
Abby: together at Ventana Medical Systems
About
Experienced scientific leader with nearly two decades directing R&D teams across oncology diagnostics development. Brings expertise spanning research, regulatory submission and product approval, including immunohistochemistry assays, next-generation sequencing panels, and multi-omic machine learning assays for early cancer detection, with specialized focus on manufacturing scale-up and clinical validation.
Executive at AOA DxYC S21
Intro paths
YC
AOA Dx went through Y Combinator (Summer 2021) — Abby is an executive there, so any YC alum in your network can reach them through the company's founders.
GP
AOA Dx's group partner at YC was Jared Friedman, YC Group Partner — the partner who ran AOA Dx's batch and knows the company first-hand. YC profile ↗
→
In turn, Abby can intro founders to AOA Dx's investors below.
AOA Dx's investors · 26
Alley Robotics VenturesCohasset · $500K – $2M checksAlleyCorpNew York · $1M – $5M checksAstiaSilicon ValleyAurum Venture PartnersPleasantonBantam GroupWestwoodBeacon AngelsBoston · $50K – $400K checksCancer FundPhoenixCreative Destruction Lab (CDL)Toronto · $50K – $250K checksEmmeline VenturesParadise Valley · $50K – $500K checksFemHealth VenturesShort HillsForeground CapitalBostonGood Growth CapitalCharlestonGore Range CapitalSouthlake · $500K – $5M checksHelmNew York · $500K checksJoyance PartnersBerlinKube VCLaunchpad Venture GroupBoston · $8M – $10M checksLongeVCWashington D.C.Olive Tree CapitalBostonOxonian VenturesPalo AltoService Provider CapitalVailTBD AngelsNew YorkUndeterred CapitalLos Angeles · $500K – $1M checksVU Venture PartnersSan Francisco · $200K – $1M checksWalnut Venture AssociatesWellesleyY CombinatorSan Francisco · $500K checks · since 2021
Co-founders at AOA Dx
OP
Oriana Papin-ZoghbiFounder
AF
Alex FisherFounder/COO
AJ
Anna JeterFounder
OZ
Oriana Zoghbi-HarbExecutive Officer, Director
Experience
- AOA DxChief Scientific Officercurrent2024 — presentDenver, Colorado, United States
- Thrive, An Exact Sciences CompanyHead Of Research And Development2021 — 2024Cambridge, Massachusetts, United States
- Personal Genome DiagnosticsSVP, Research, Development and Operations2016 — 2021Washington DC-Baltimore Area
- Ventana Medical SystemsVice President, Assay and Reagent Development2013 — 2016Greater Tucson Area
- Ventana Medical SystemsSenior Project Leader, Companion Diagnostic Assay Development2012 — 2013Tucson AZ
- Ventana Medical SystemsProject Leader2010 — 2012
- RocheVP Assay And Reagent Development2006 — 2016Roche Tissue Diagnostics
- Ventana Medical SystemsSenior Manager, Molecular Probes2008 — 2010
- Ventana Medical SystemsSenior Scientist2006 — 2008
- Aastrom BiosciencesSenior Scientist2005 — 2006
- University of ArizonaPost-doctoral fellow1998 — 2002
Skills & more
Product Development2Building World Class Teams2Creative Problem Solving2Biotechnology70Assay Development64Medical Devices28Molecular Biology33Life Sciences28Lifesciences26Oncology18Genomics13Commercialization14
+12 more
ImmunohistochemistryFDAImmunologyInfectious DiseasesDrug DiscoveryCross-functional Team LeadershipBiomarkersImmunoassaysManagementLeadershipResearch and Development (R&D)Clinical DevelopmentFrom Abby's professional profile.
Colleagues at AOA Dx
Alex Fisher
Chief Operating Officer & Co-Founder at AOA Dx
Anna Jeter
Chief Regulatory Officer & Co-Founder at AOA Dx
Cory Bystrom
Senior Director, Biomarker & Analytical Development at AOA Dx
Drew Watson
Clinical Advisor at AOA Dx
Elizabeth Yarber
Senior Director of Clinical Operations at AOA Dx
Emily Chang
Director, R&D at AOA Dx
James White
Scientific Advisor at AOA Dx
John Friedman
Board Member at AOA Dx
Frequently asked questions
- Who is Abby McElhinny?
- Experienced scientific leader with nearly two decades directing R&D teams across oncology diagnostics development. Brings expertise spanning research, regulatory submission and product approval, including immunohistochemistry assays, next-generation sequencing panels, and multi-omic machine learning assays for early cancer detection, with specialized focus on manufacturing scale-up and clinical validation.
- Where does Abby McElhinny work?
- Abby McElhinny is Chief Scientific Officer at AOA Dx.
- Where did Abby McElhinny go to school?
- Abby McElhinny studied at Northeastern University (Ph.D., Immunology/Biochemistry).
Same school
Also attended Northeastern University477
Matt GuineyChief Financial Officer at Flybridge Capital PartnersAllison KuziwGlobal Human Resources Executive at Marlin Equity PartnersSaunaz MoradiPartner, Communications at Lux CapitalBrian DixonManaging Partner at Kapor CapitalMurat BicerGeneral Partner at CRV (Charles River Ventures)Christopher WolfChief Financial Officer at MPM BioImpact
+ 471 more
Shared employers
Also worked at AOA Dx13
Alice ZhengPartner at Foreground CapitalByron HewettExecutives in Residence at GENERAL INCEPTIONAnthony BajorasFounder, Managing Director at Cancer FundVictoria PettiboneManaging Partner at AstiaSharon VosmekManaging Director at AstiaOriana Papin-ZoghbiChief Executive Officer & Co-Founder at AOA Dx
+ 7 more
Also worked at Personal Genome Diagnostics8
Vuna FaSenior Director of R&D at AOA DxEmily ChangDirector, R&D at AOA DxDoug WardCEO at Lumos DiagnosticsLisa KannExecutive Officer at Personal Genome DiagnosticsSam AngiuoliExecutive Officer at Personal Genome DiagnosticsWilliam J StevensExecutive Officer at Personal Genome Diagnostics
+ 2 more
Also worked at Ventana Medical Systems13
Fabien GaireSenior Director at Roche at PICUS CAPITALMara AspinallCo-Founder and Executive Consultant at BlueStone Venture PartnersSteve BurnellManaging Director; Chair of the Investment Committee at TenmileVuna FaSenior Director of R&D at AOA DxKaren EatonFounder/CEO at Sigma GeneticsMichael A. GaulChief Operating Officer at Beyond Air
+ 7 more
